Acute/JJ
leukemia/NN
with/IN
promyelocytic/JJ
features/NNS
in/IN
PML/RARalpha/NN
transgenic/JJ
mice/NNS
./.

Acute/JJ
promyelocytic/JJ
leukemia/NN
(/(
APL/NN
)/)
is/VBZ
associated/VBN
with/IN
reciprocal/JJ
chromosomal/JJ
translocations/NNS
involving/VBG
the/DT
retinoic/JJ
acid/NN
receptor/NN
alpha/NN
(/(
RARalpha/NN
)/)
locus/NN
on/IN
chromosome/NN
17/CD
./.
=====
In/IN
the/DT
majority/NN
of/IN
cases/NNS
,/,
RARalpha/NN
translocates/VBZ
and/CC
fuses/VBZ
with/IN
the/DT
promyelocytic/JJ
leukemia/NN
(/(
PML/NN
)/)
gene/NN
located/JJ
on/IN
chromosome/NN
15/CD
./.
=====
The/DT
resulting/VBG
fusion/NN
genes/NNS
encode/VBP
the/DT
two/CD
structurally/RB
unique/JJ
PML/RARalpha/NN
and/CC
RARalpha/PML/NN
fusion/NN
proteins/NNS
as/RB
well/RB
as/IN
aberrant/JJ
PML/NN
gene/NN
products/NNS
,/,
the/DT
respective/JJ
pathogenetic/JJ
roles/NNS
of/IN
which/WDT
have/VBP
not/RB
been/VBN
elucidated/VBN
./.
=====
We/PRP
have/VBP
generated/VBN
transgenic/JJ
mice/NNS
in/IN
which/WDT
the/DT
PML/RARalpha/NN
fusion/NN
protein/NN
is/VBZ
specifically/RB
expressed/VBN
in/IN
the/DT
myeloid-promyelocytic/JJ
lineage/NN
./.
=====
During/IN
their/PRP$
first/JJ
year/NN
of/IN
life/NN
,/,
all/PDT
the/DT
PML/RARalpha/NN
transgenic/JJ
mice/NNS
have/VBP
an/DT
abnormal/JJ
hematopoiesis/NN
that/WDT
can/MD
best/RB
be/VB
described/VBN
as/IN
a/DT
myeloproliferative/JJ
disorder/NN
./.
=====
Between/IN
12/CD
and/CC
14/CD
months/NNS
of/IN
age/NN
,/,
10/CD
%/NN
of/IN
them/PRP
develop/VBP
a/DT
form/NN
of/IN
acute/JJ
leukemia/NN
with/IN
a/DT
differentiation/NN
block/NN
at/IN
the/DT
promyelocytic/JJ
stage/NN
that/WDT
closely/RB
mimics/VBZ
human/JJ
APL/NN
even/RB
in/IN
its/PRP$
response/NN
to/TO
retinoic/JJ
acid/NN
./.
=====
Our/PRP$
results/NNS
are/VBP
conclusive/JJ
in/FW
vivo/FW
evidence/NN
that/IN
PML/RARalpha/NN
plays/VBZ
a/DT
crucial/JJ
role/NN
in/IN
the/DT
pathogenesis/NN
of/IN
APL/NN
./.